Polyethylenimine but Not Cationic Lipid Improves Antisense Activity of 3′-Capped Phosphodiester Oligonucleotides
- 1 December 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 9 (6) , 515-525
- https://doi.org/10.1089/oli.1.1999.9.515
Abstract
Lipofectin, which is a mixture of neutral lipid with a cationic lipid, has been widely used to enhance cellular delivery of phosphorothioate, 2'-sugar-modified, and chimeric antisense oligonucleotides. Phosphodiester oligonucleotides delivered with Lipofectin usually do not elicit antisense activity probably because cationic lipid formulations do not sufficiently protect unmodified oligonucleotides from nuclease degradation. We show that a cationic polymer, polyethylenimine (PEI), improves the uptake and antisense activity of 3'-capped 20-mer and 12-mer antisense phosphodiester oligonucleotides (PO-ODN) targeted to different regions of Ha-ras mRNA and to the 3'-untranslated region (3'-UTR) of C-raf kinase. In contrast, PEI, which forms a very stable complex with the 20-mer phosphorothioate oligonucleotide (PS-ODN), does not enhance its antisense activity. Using fluorescently labeled carriers and ODN, we show that PEI-PS-ODN particles are very efficiently taken up by cells but PS-ODN is not dissociated from the carrier. Our results indicate that carrier-ODN particle size and stability and ODN release kinetics vary with the chemical nature of the ODN and the carrier being transfected into the cells. The very low cost of PEI compared with cytofectins and the increased affinity for target mRNA and decreased affinity for proteins of PO-ODN compared with PS-ODN make the use of PEI-PO-ODN very attractive.Keywords
This publication has 22 references indexed in Scilit:
- In vivo studies with antisense oligonucleotidesTrends in Pharmacological Sciences, 1997
- A Powerful Nonviral Vector for In Vivo Gene Transfer into the Adult Mammalian Brain: PolyethylenimineHuman Gene Therapy, 1996
- Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinaseNature Medicine, 1996
- Nuclease Resistance and Antisense Activity of Modified Oligonucleotides Targeted to Ha-Published by Elsevier ,1996
- Polyethylenimine-Mediated DNA Transfection of Peripheral and Central Neurons in Primary Culture: Probing Ca2+Channel Structure and Function with Antisense OligonucleotidesMolecular and Cellular Neuroscience, 1996
- Does antisense exist?Nature Medicine, 1995
- Conjugation of Oligonucleotides to 3′‐Polar MoietiesBulletin des Sociétés Chimiques Belges, 1995
- Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.Proceedings of the National Academy of Sciences, 1994
- An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of aminesAnalytical Biochemistry, 1975
- Improved mountant for immunofluorescence preparations.Journal of Clinical Pathology, 1974